Forbion Closes Oversubscribed Fourth Life Sciences VC Fund at EUR 360 million
Investment focus is on new drugs and technologies
02-Oct-2018 -
Forbion has announced the final close of its new flagship fund, Forbion IV. The oversubscribed fund closed at EUR 360 million in capital commitments, significantly above its original target of EUR 250 million. Forbion IV, like its predecessor fund, Forbion III, will primarily focus on ...
investments
start-ups
venture capital